Valley Brook Capital Group, Inc. Abb Vie Inc. Transaction History

Valley Brook Capital Group, Inc.

$127 Million
Q1 2024

A detailed history of Valley Brook Capital Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 22,749 shares of ABBV stock, worth $3.9 Million. This represents 3.26% of its overall portfolio holdings.

Number of Shares

22,749

Previous 22,845 0.42%

Holding current value

$3.9 Million

Previous $3.54 Million 17.01%

% of portfolio

3.26%

Previous 3.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $15,342 - $17,481	-96 Reduced 0.42%	22,749 $4.14 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $17,612 - $19,836	128 Added 0.56%	22,845 $3.54 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $62,520 - $72,376	468 Added 2.1%	22,717 $3.39 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $118,066 - $146,925	-891 Reduced 3.85%	22,249 $3 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $34,561 - $39,803	-239 Reduced 1.02%	23,140 $3.69 Million

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $49,376 - $59,215	357 Added 1.55%	23,379 $3.78 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $14,360 - $16,470	107 Added 0.47%	23,022 $3.09 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $55,048 - $69,984	-400 Reduced 1.72%	22,915 $3.51 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $159,167 - $197,482	1,206 Added 5.45%	23,315 $3.78 Million
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $22,345 - $28,273	208 Added 0.95%	22,109 $2.99 Million
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $119,487 - $135,635	-1,123 Reduced 4.88%	21,901 $2.36 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $65,966 - $73,490	627 Added 2.8%	23,024 $2.59 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $62,403 - $68,698	610 Added 2.8%	22,397 $2.42 Million
Q4 2020 Mar 19, 2021	BUY	$80.49 - $108.67 $1.75 Million - $2.37 Million	21,787 New	21,787 $2.33 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley Brook Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valley Brook Capital Group, Inc. with notifications on news.

Account

Valley Brook Capital Group, Inc. Abb Vie Inc. Transaction History